Further zooming into the impacts of GLP-1 on food consumption, a Morgan Stanley Research report provides interesting early insights on how GLP-1 users eating habits are changing (see figure below)
As of 2024, survey results from the KFF Health Tracking Poll showed that about 13 per cent of American adults have used a GLP-1 agonist, a class of drugs prescribed for weight loss, to treat diabetes, or to reduce the risk of heart attack and stroke in adults with heart disease
At 5 mg/ml, 2.5 mg equals 0.50 ml
Researchers can correlate experimental binding data with molecular docking, dynamic simulations, and pathway analysis , establishing a robust framework for interpreting peptide-receptor interactions at both molecular and systems levels
It is believed that untreated/ uncontrolled/poorly treated diabetes can cause damage to blood vessels, including vessels in the brain
Sands SA, Edwards BA, Terrill PI, et al